Speakers
![Colin Church](https://taskfilescsm.s3.amazonaws.com:443/uploads/speaker_thumb/2024-06-1214%253A09%253A33292504-ColinChurch.jpg)
Colin Church
Consultant in Pulmonary Vascular and Respiratory Medicine,
Queen Elizabeth University Hospital
Dr Church is a consultant in pulmonary vascular and respiratory medicine. He trained in Glasgow, Cambridge, Papworth and Sydney. He has completed a PhD in understanding the basic mechanisms of inflammatory signaling in pulmonary vascular remodeling. He has a keen interest in both clinical and basic science research and is a principal investigator on a number of important clinical trials including looking at novel anti-inflammatory strategies to treat pulmonary hypertension. His basic science research focuses on the interplay of inflammation and hypoxia on the pulmonary vascular cells in particular the pulmonary artery fibroblast. He is one of 3 consultants in the Scottish Pulmonary Vascular Unit which is the national referral centre for the Scottish Population. This unit investigates and manages all patients in Scotland with pulmonary hypertension. He is also one of the principal clinicians involved in management of venous thromboembolic disease in the Queen Elizabeth University Hospital and is the secretary of the Glasgow & Clyde Thrombosis committee. He is chair of the British Thoracic Society SAG on pulmonary vascular disease.
Sessions
-
01-Oct-2024AGM Clinical Theatre CPulmonary hypertension for the general medic